The REMS, originally designed to reduce the risk of clozapine-related neutropenia, has instead created substantial and avoidable barriers to basic care. As part of this REMS program, prescribers ...

Living Local 15 host Jessica Williams is joined by Sean Goddard, a Psychiatric Nurse Practitioner and Owner of Viking Psychiatry, to speak about the recent approval for Spravato as a monotherapy ...

If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Most physicians said the positives of clozapine's REMS outweighed its negatives. Most also said that mandatory blood ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment ... Firstly, it needs to be administered at certified treatment centres, and it also has a boxed warning on the risk of ...

Only drugs with inpatient-applicable REMS requirements were included in the initial evaluation. Of the 145 drugs evaluated, 123 were excluded from the project because the associated REMS were ...

What is the CRISC difference? A Certified in Risk and Information Systems Control ® (CRISC ®) certification demonstrates your IT risk management expertise. By taking a proactive approach, you will ...